Elif Bilgin

411 total citations
33 papers, 310 citations indexed

About

Elif Bilgin is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Elif Bilgin has authored 33 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Elif Bilgin's work include Cell Adhesion Molecules Research (6 papers), Cancer Cells and Metastasis (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Elif Bilgin is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), Cancer Cells and Metastasis (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Elif Bilgin collaborates with scholars based in Türkiye and Germany. Elif Bilgin's co-authors include Derya Duranyıldız, Faruk Taş, Kayhan Ertürk, Didem Taştekin, Senem Karabulut, Vildan Yasasever, Murat Serilmez, Leyla Kılıç, Faruk Taş and Rümeysa Çiftçi and has published in prestigious journals such as Biomedicine & Pharmacotherapy, Cytokine and Biomolecules.

In The Last Decade

Elif Bilgin

33 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elif Bilgin Türkiye 12 130 124 85 66 53 33 310
Maria Ossolińska Poland 12 142 1.1× 117 0.9× 65 0.8× 113 1.7× 79 1.5× 28 353
Lihou Dong China 9 86 0.7× 163 1.3× 34 0.4× 56 0.8× 51 1.0× 19 294
Luciana Tanca Italy 7 101 0.8× 158 1.3× 56 0.7× 69 1.0× 118 2.2× 9 401
Hee Jung Kwon South Korea 13 106 0.8× 101 0.8× 62 0.7× 54 0.8× 63 1.2× 41 590
Chia-Li Yu Taiwan 8 111 0.9× 98 0.8× 63 0.7× 51 0.8× 107 2.0× 11 334
Kiyoshi Kamada Japan 8 269 2.1× 84 0.7× 91 1.1× 87 1.3× 43 0.8× 26 433
Alice Giacobino Italy 10 111 0.9× 242 2.0× 81 1.0× 47 0.7× 89 1.7× 10 358
Hiroyuki Maeta Japan 11 191 1.5× 146 1.2× 96 1.1× 79 1.2× 38 0.7× 24 419
Yuichi Terado Japan 12 104 0.8× 106 0.9× 32 0.4× 126 1.9× 51 1.0× 27 367
Šárka Svobodová Czechia 13 75 0.6× 132 1.1× 45 0.5× 61 0.9× 27 0.5× 27 299

Countries citing papers authored by Elif Bilgin

Since Specialization
Citations

This map shows the geographic impact of Elif Bilgin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elif Bilgin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elif Bilgin more than expected).

Fields of papers citing papers by Elif Bilgin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elif Bilgin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elif Bilgin. The network helps show where Elif Bilgin may publish in the future.

Co-authorship network of co-authors of Elif Bilgin

This figure shows the co-authorship network connecting the top 25 collaborators of Elif Bilgin. A scholar is included among the top collaborators of Elif Bilgin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elif Bilgin. Elif Bilgin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karabulut, Senem, Çiğdem Usul Afşar, Mehmet Karabulut, et al.. (2017). Clinical significance of serum interleukin-17 levels in colorectal cancer patients.. PubMed. 21(5). 1137–1145. 7 indexed citations
2.
Karabulut, Mehmet, Çiğdem Usul Afşar, Halil Alış, et al.. (2017). Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer. Molecular and Clinical Oncology. 7(5). 787–797. 2 indexed citations
3.
Karabulut, Senem, Mehmet Karabulut, Çiğdem Usul Afşar, et al.. (2016). PANKREAS ADENOKARSİNOMLU HASTALARDA SERUM TRANSFORME EDİCİ BÜYÜME FAKTÖR BETA 1 (TGF-Β1) DÜZEYLERİ. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi. 79(1). 9–9. 1 indexed citations
4.
Taş, Faruk, Elif Bilgin, Senem Karabulut, & Derya Duranyıldız. (2016). Clinical significance of serum laminin and type-IV collagen levels in cutaneous melanoma patients. Molecular and Clinical Oncology. 5(1). 195–200. 4 indexed citations
5.
Duranyıldız, Derya, et al.. (2016). Circulating serum levels of angiopoietin-1 and angiopoietin-2 in nasopharynx and larynx carcinoma patients. Tumor Biology. 37(7). 8979–8983. 5 indexed citations
6.
Taş, Faruk, Elif Bilgin, Didem Taştekin, Kayhan Ertürk, & Derya Duranyıldız. (2016). Clinical significance of serum laminin levels in patients with lung cancer. Biomedical Reports. 4(4). 485–488. 6 indexed citations
7.
Taş, Faruk, Elif Bilgin, Senem Karabulut, Kayhan Ertürk, & Derya Duranyıldız. (2016). Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma. PubMed. 5. 166–169. 2 indexed citations
8.
Taş, Faruk, Elif Bilgin, Kayhan Ertürk, & Derya Duranyıldız. (2016). Clinical significance of serum claudin-1 levels in melanoma patients. Melanoma Research. 26(4). 377–381. 4 indexed citations
9.
Taş, Faruk, Elif Bilgin, Didem Taştekin, Kayhan Ertürk, & Derya Duranyıldız. (2016). Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients. Journal of Gastrointestinal Cancer. 47(2). 182–186. 9 indexed citations
10.
Ertürk, Kayhan, et al.. (2015). Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer. Tumor Biology. 37(1). 405–412. 16 indexed citations
11.
Taş, Faruk, Senem Karabulut, Elif Bilgin, & Derya Duranyıldız. (2014). Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy. Tumor Biology. 35(8). 7871–7875. 6 indexed citations
12.
Taş, Faruk, Senem Karabulut, Elif Bilgin, Didem Taştekin, & Derya Duranyıldız. (2014). Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer. Tumor Biology. 35(9). 9303–9309. 18 indexed citations
13.
Taş, Faruk, Senem Karabulut, Elif Bilgin, Didem Taştekin, & Derya Duranyıldız. (2014). Clinical significance of serum fibronectin and vitronectin levels in melanoma patients. Melanoma Research. 24(5). 475–479. 11 indexed citations
14.
Bilgin, Elif, et al.. (2013). miR-141 and miR-375 induction and release are different from PSA mRNA and PCA3 upon androgen stimulation of LNCaP cells. Biomedical Reports. 1(5). 802–806. 12 indexed citations
15.
Bilgin, Elif, et al.. (2013). For Which Cancer Types can Neuron-Specific Enolase be Clinically Helpful in Turkish Patients?. Asian Pacific Journal of Cancer Prevention. 14(4). 2541–2544. 5 indexed citations
16.
Taş, Faruk, Senem Karabulut, Elif Bilgin, et al.. (2013). Clinical Significance of Coagulation Assays in Metastatic Pancreatic Adenocarcinoma. Journal of Gastrointestinal Cancer. 44(4). 404–409. 7 indexed citations
17.
Taş, Faruk, Senem Karabulut, Elif Bilgin, et al.. (2013). Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma. Tumor Biology. 34(6). 3529–3536. 5 indexed citations
18.
Taş, Faruk, Rümeysa Çiftçi, Leyla Kılıç, et al.. (2012). Clinical and prognostic significance of coagulation assays in melanoma. Melanoma Research. 22(5). 368–375. 15 indexed citations
19.
Taş, Faruk, Leyla Kılıç, Elif Bilgin, et al.. (2012). Clinical and Prognostic Significance of Coagulation Assays in Advanced Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 23(2). 276–281. 25 indexed citations
20.
Bilgin, Elif, et al.. (2012). Markers of Bone Metastases in Breast and Lung Cancers. Asian Pacific Journal of Cancer Prevention. 13(9). 4331–4334. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Ossolińska Breakdown of academic impact, for papers by Lihou Dong Breakdown of academic impact, for papers by Luciana Tanca Breakdown of academic impact, for papers by Hee Jung Kwon Breakdown of academic impact, for papers by Chia-Li Yu Breakdown of academic impact, for papers by Kiyoshi Kamada Breakdown of academic impact, for papers by Alice Giacobino Breakdown of academic impact, for papers by Hiroyuki Maeta Breakdown of academic impact, for papers by Yuichi Terado Breakdown of academic impact, for papers by Šárka Svobodová
Rankless by CCL
2026